REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Brightgene Bio-Medical Technology Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Brightgene Bio-Medical Technology Co., Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Brightgene Bio-Medical Technology Co., Ltd. is a chemical and pharmaceutical industry chain product and technology platform enterprise that develops and participates in international competition. The company was founded in 2001 and is headquartered in Suzhou City, China.

Headquarters
Building C25-C28, Nano Science and Technology Park, No. 218 Xinghu Street, Industrial Park, Suzhou City, Jiangsu Province
Suzhou; Jiangsu; Postal Code: 215123

Contact Details: Purchase the Brightgene Bio-Medical Technology Co., Ltd. report to view the information.

Website: http://www.bright-gene.com

Basic Information
Total Employees:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. report to view the information.
Registered Capital:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. report to view the information.
Incorporation Date:
October 26, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
26.87%
Purchase this report to view the information.
6.34%
Purchase this report to view the information.
5.34%
Purchase this report to view the information.
4.41%
Purchase this report to view the information.
2.76%
Subsidiaries
BRIGHTGENE EUROPE GMGH I.GR.
100%
Borui Bio-Pharmaceutical Taixing City Co., Ltd.
100%
Borui Biological (Hong Kong) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Brightgene Bio-Medical Technology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
6.77%▲
Total operating revenue
6.76%▲
Operating profit (EBIT)
-14.96%▼
Net Profit (Loss) for the Period
-16.96%▼
Total assets
-1.76%▼
Total equity
-4.03%▼
Operating Profit Margin (ROS)
-4.41%▼
Net Profit Margin
-4.3%▼
Return on Equity (ROE)
-0.97%▼
Debt to Equity Ratio
-0.43%▼
Quick Ratio
-0.57%▼
Cash Ratio
-0.56%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanghai New World Co.,Ltd
 
Inner Mongolia Furui Medical Science Co., Ltd.
Lanzhou Foci Pharmaceutical Co.,Ltd.
 
Guangdong Hybribio Biotech Co.,Ltd.
Chengdu Easton Bio Pharmaceuticals Co.,Ltd
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo